215 related articles for article (PubMed ID: 26741508)
1. Tumor sialylation impedes T cell mediated anti-tumor responses while promoting tumor associated-regulatory T cells.
Perdicchio M; Cornelissen LA; Streng-Ouwehand I; Engels S; Verstege MI; Boon L; Geerts D; van Kooyk Y; Unger WW
Oncotarget; 2016 Feb; 7(8):8771-82. PubMed ID: 26741508
[TBL] [Abstract][Full Text] [Related]
2. Sorafenib relieves cell-intrinsic and cell-extrinsic inhibitions of effector T cells in tumor microenvironment to augment antitumor immunity.
Chen ML; Yan BS; Lu WC; Chen MH; Yu SL; Yang PC; Cheng AL
Int J Cancer; 2014 Jan; 134(2):319-31. PubMed ID: 23818246
[TBL] [Abstract][Full Text] [Related]
3. Accumulation of cytolytic CD8+ T cells in B16-melanoma and proliferation of mature T cells in TIS21-knockout mice after T cell receptor stimulation.
Ryu MS; Woo MY; Kwon D; Hong AE; Song KY; Park S; Lim IK
Exp Cell Res; 2014 Oct; 327(2):209-21. PubMed ID: 25088256
[TBL] [Abstract][Full Text] [Related]
4. Sialic Acid Blockade Suppresses Tumor Growth by Enhancing T-cell-Mediated Tumor Immunity.
Büll C; Boltje TJ; Balneger N; Weischer SM; Wassink M; van Gemst JJ; Bloemendal VR; Boon L; van der Vlag J; Heise T; den Brok MH; Adema GJ
Cancer Res; 2018 Jul; 78(13):3574-3588. PubMed ID: 29703719
[TBL] [Abstract][Full Text] [Related]
5. Effects of interleukin-1 receptor antagonist and chemotherapy on host-tumor interactions in established melanoma.
Triozzi PL; Aldrich W
Anticancer Res; 2010 Feb; 30(2):345-54. PubMed ID: 20332438
[TBL] [Abstract][Full Text] [Related]
6. Tumoral expression of IL-33 inhibits tumor growth and modifies the tumor microenvironment through CD8+ T and NK cells.
Gao X; Wang X; Yang Q; Zhao X; Wen W; Li G; Lu J; Qin W; Qi Y; Xie F; Jiang J; Wu C; Zhang X; Chen X; Turnquist H; Zhu Y; Lu B
J Immunol; 2015 Jan; 194(1):438-45. PubMed ID: 25429071
[TBL] [Abstract][Full Text] [Related]
7. A transplantable TH-MYCN transgenic tumor model in C57Bl/6 mice for preclinical immunological studies in neuroblastoma.
Kroesen M; Nierkens S; Ansems M; Wassink M; Orentas RJ; Boon L; den Brok MH; Hoogerbrugge PM; Adema GJ
Int J Cancer; 2014 Mar; 134(6):1335-45. PubMed ID: 24038106
[TBL] [Abstract][Full Text] [Related]
8. Natural killer cells prevent CD28-mediated Foxp3 transcription in CD4+CD25- T lymphocytes.
Brillard E; Pallandre JR; Chalmers D; Ryffel B; Radlovic A; Seilles E; Rohrlich PS; Pivot X; Tiberghien P; Saas P; Borg C
Exp Hematol; 2007 Mar; 35(3):416-25. PubMed ID: 17309822
[TBL] [Abstract][Full Text] [Related]
9. Preclinical modeling of EGFR-specific antibody resistance: oncogenic and immune-associated escape mechanisms.
Garrido G; Rabasa A; Garrido C; López A; Chao L; García-Lora AM; Garrido F; Fernández LE; Sánchez B
Oncogene; 2014 Jun; 33(24):3129-39. PubMed ID: 23975426
[TBL] [Abstract][Full Text] [Related]
10. Sialic acid-modified antigens impose tolerance via inhibition of T-cell proliferation and de novo induction of regulatory T cells.
Perdicchio M; Ilarregui JM; Verstege MI; Cornelissen LA; Schetters ST; Engels S; Ambrosini M; Kalay H; Veninga H; den Haan JM; van Berkel LA; Samsom JN; Crocker PR; Sparwasser T; Berod L; Garcia-Vallejo JJ; van Kooyk Y; Unger WW
Proc Natl Acad Sci U S A; 2016 Mar; 113(12):3329-34. PubMed ID: 26941238
[TBL] [Abstract][Full Text] [Related]
11. Sustained IL-2R signaling of limited duration by high-dose mIL-2/mCD25 fusion protein amplifies tumor-reactive CD8
Hernandez R; Toomer KH; Põder J; Santos Savio A; Hsiung S; Malek TR
Cancer Immunol Immunother; 2021 Apr; 70(4):909-921. PubMed ID: 33037893
[TBL] [Abstract][Full Text] [Related]
12. Peroxisome proliferator-activated receptor alpha deficiency impairs regulatory T cell functions: Possible application in the inhibition of melanoma tumor growth in mice.
Hichami A; Yessoufou A; Ghiringhelli F; Salvadori F; Moutairou K; Zwetyenga N; Khan NA
Biochimie; 2016 Dec; 131():1-10. PubMed ID: 27613402
[TBL] [Abstract][Full Text] [Related]
13. Amphiregulin activates regulatory T lymphocytes and suppresses CD8+ T cell-mediated anti-tumor response in hepatocellular carcinoma cells.
Yuan CH; Sun XM; Zhu CL; Liu SP; Wu L; Chen H; Feng MH; Wu K; Wang FB
Oncotarget; 2015 Oct; 6(31):32138-53. PubMed ID: 26451607
[TBL] [Abstract][Full Text] [Related]
14. Loss of prolyl hydroxylase-2 in myeloid cells and T-lymphocytes impairs tumor development.
Mamlouk S; Kalucka J; Singh RP; Franke K; Muschter A; Langer A; Jakob C; Gassmann M; Baretton GB; Wielockx B
Int J Cancer; 2014 Feb; 134(4):849-58. PubMed ID: 23913502
[TBL] [Abstract][Full Text] [Related]
15. Low-dose cisplatin converts the tumor microenvironment into a permissive state for HSVtk-induced antitumor immunity in HPV16-related tonsillar carcinoma.
Goh AR; Shin SP; Jung NR; Ryu CH; Eom HS; Lee JH; Choi K; Lee SJ; Jung YS
Cancer Lett; 2015 Jan; 356(2 Pt B):743-50. PubMed ID: 25449436
[TBL] [Abstract][Full Text] [Related]
16. Homeostatic proliferation plus regulatory T-cell depletion promotes potent rejection of B16 melanoma.
Kline J; Brown IE; Zha YY; Blank C; Strickler J; Wouters H; Zhang L; Gajewski TF
Clin Cancer Res; 2008 May; 14(10):3156-67. PubMed ID: 18483384
[TBL] [Abstract][Full Text] [Related]
17. Immune microenvironment profiles of tumor immune equilibrium and immune escape states of mouse sarcoma.
Wu X; Peng M; Huang B; Zhang H; Wang H; Huang B; Xue Z; Zhang L; Da Y; Yang D; Yao Z; Zhang R
Cancer Lett; 2013 Oct; 340(1):124-33. PubMed ID: 23920127
[TBL] [Abstract][Full Text] [Related]
18. High intensity focused ultrasound enhances anti-tumor immunity by inhibiting the negative regulatory effect of miR-134 on CD86 in a murine melanoma model.
Yuan SM; Li H; Yang M; Zha H; Sun H; Li XR; Li AF; Gu Y; Duan L; Luo JY; Li CY; Wang Y; Wang ZB; He TC; Zhou L
Oncotarget; 2015 Nov; 6(35):37626-37. PubMed ID: 26485753
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of Tumor-infiltrating Leukocyte Subsets in a Subcutaneous Tumor Model.
Pachynski RK; Scholz A; Monnier J; Butcher EC; Zabel BA
J Vis Exp; 2015 Apr; (98):. PubMed ID: 25938949
[TBL] [Abstract][Full Text] [Related]
20. High-fat diet-induced obesity increases lymphangiogenesis and lymph node metastasis in the B16F10 melanoma allograft model: roles of adipocytes and M2-macrophages.
Jung JI; Cho HJ; Jung YJ; Kwon SH; Her S; Choi SS; Shin SH; Lee KW; Park JH
Int J Cancer; 2015 Jan; 136(2):258-70. PubMed ID: 24844408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
